Vasoactive intestinal peptide (VIP) primarily exerts its effects through the VPAC(1) and VPAC(2) receptors, activating adenylate cyclase and increasing intracellular cAMP levels, which subsequently influences various biological processes such as neurotransmission, neuroendocrine regulation, and immune responses. VIP's role in modulating cardiac activity, digestion, and neuronal survival is mediated through these receptor-mediated signaling pathways, although the complete mechanistic details remain to be fully elucidated. Additionally, VIP has been implicated in cancer proliferation and immune suppression, highlighting its diverse physiological and pathological functions.